For your discernment....
Dr. Halamka serves as the Chief Information Officer of Harvard Medical School, Chief Information Officer of Beth Israel Deaconess Medical Center, Chief Information Officer of the Harvard Clinical Research Institute, and an Associate Professor of Emergency Medicine at Harvard Medical School. Dr. Halamka also serves on other nationally recognized boards including Google’s Health Advisory Council.
“Dr. Halamka, who was one of the first individuals to get a VeriMed microchip in his arm, is unquestionably a visionary in the health information technology arena. He is a proven advocate for patient safety and a champion for patient privacy related to new technologies,” stated Scott. R. Silverman, Chairman and Chief Executive Officer of VeriChip Corporation. “We are proud to have someone of his stature join our Medical Advisory Board.”
Commenting on his appointment, Dr. Halamka noted, “Each patient weighs the risks and benefits of receiving an implanted chip. It is critical that implanted chips adhere to industry standards and protect patient confidentiality. I look forward to advising VeriChip Corporation to ensure its technology continues to meet these requirements.”
VeriChip Corporation’s Medical Advisory Board is a team of key thought leaders with diverse experience in clinical and academic medicine, as well as business development and corporate leadership. The Medical Advisory Board provides strategic advice to the Company in the areas of medical issues, clinical studies and product development.
No comments:
Post a Comment